Delivery Order SPE2DP16D0006-0003
Award Date 7/19/16
Potential Completion Date 1/3/17
Potential Value $2.4M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $9,033,542.56, was issued by the Defense Department's Medical Supply Chain agency to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of influenza virus vaccines. The contract has a firm fixed price structure and an ultimate completion date of October 17, 2016. It is not designated as a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This federal contract award with ID SPE2DP24D0005|SPE2DP24F3249 is for the delivery of influenza virus vaccines. The contract was awarded on March 14, 2024 to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $1,551,550.00 and is a firm fixed price delivery order contract with no set-aside designation. The...
- This federal contract award, with ID SPE2DP16D0006|0005, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The $282,870.56 firm fixed price delivery order has an ultimate completion date of November 30, 2016 and does not have a set-aside designation. Glaxosmithkline, LLC is a prime contractor that has received various federal contract and grant awards to supply...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0456, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The contract is a firm fixed-price Delivery Order with a ceiling value of $173,368.80 and a period of performance ending on November 8, 2018. The contract was not set aside for any specific business designation. Glaxosmithkline, LLC has provided a range of pharmaceutical goods and...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- This federal contract award, with ID HHSP284201600040A, was issued by the Office of the Assistant Secretary for Administration (a civilian agency) to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $2,477,205.82 firm fixed-price contract has an ultimate completion date of October 13, 2016. Glaxosmithkline is a prime contractor on this award and has also received federal grant subawards and multiple award indefinite delivery vehicles (IDVs) from agencies like...
- This federal contract award, SPE2DP15D0006|0008, was issued by the U.S. Defense Logistics Agency (DLA) to the prime contractor GlaxoSmithKline, LLC for the delivery of influenza virus vaccines. The $100,660.00 firm fixed price contract has a completion date of November 30, 2015 and does not have a set-aside designation. GlaxoSmithKline is a global pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contracts...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...